Medpace surges 45% following earnings beats, 2025 guidance updates

6 hours ago 1

Medpace Holdings (NASDAQ:MEDP) is up 45% in after-hours trading Monday after posting Q2 financial results that beat on both lines and boosting its 2025 gjuidance.
The contract research organization now sees 2025 revenue of $2.42B-$2.52B, up from $2.14B to $2.24B. Consensus is $2.18B.

Recommended For You